EP Patent

EP1272220B1 — Formulation for the prevention of cardiovascular disease

Assigned to Law Malcolm R · Expires 2006-05-17 · 20y expired

What this patent protects

This invention relates to a method for the prevention of cardiovascular disease, a formulation for the prevention of cardiovascular disease, the use of specified active principals for the manufacture of such a formulation for use in the method and to a method of preparing said fo…

USPTO Abstract

This invention relates to a method for the prevention of cardiovascular disease, a formulation for the prevention of cardiovascular disease, the use of specified active principals for the manufacture of such a formulation for use in the method and to a method of preparing said formulation. The formulation of the present invention is a combination of active principals for use in the prevention of cardiovascular disease, notably ischaemic heart disease (including heart attacks) and stroke among the general adult population.

Drugs covered by this patent

Patent Metadata

Patent number
EP1272220B1
Jurisdiction
EP
Classification
—
Expires
2006-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Law Malcolm R
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.